4 commercial payer policies list 86152. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
4 policies from 4 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 86152 |
|---|---|---|
| Tumor Markers | Mar 5, 2024 | Covered |
| Policy | Effective | Status of 86152 |
|---|---|---|
| Detection of Circulating Tumor Cells | Apr 15, 2026 | Not covered |
| Policy | Effective | Status of 86152 |
|---|---|---|
| Molecular and Proteomic Diagnostic Testing for Hematology and Oncology Indications | Sep 13, 2026 | Covered |
| Policy | Effective | Status of 86152 |
|---|---|---|
| Circulating Tumor DNA and Circulating Tumor Cells for Management (Liquid Biopsy) of Solid Tumor Cancers | Jul 1, 2026 | Covered |